外泌体miRNAs在器官纤维化中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.09.1472

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (9): 1472-1476.doi: 10.16352/j.issn.1001-6325.2023.09.1472

外泌体miRNAs在器官纤维化中作用的研究进展

方路¹, 刘睿奇², 梁鹏¹, 岑瑛^2*

四川大学华西医院 1.全科医学中心日间手术中心;2.整形外科/烧伤科,四川成都 610041

收稿日期:2022-09-05 修回日期:2023-02-27 出版日期:2023-09-05 发布日期:2023-09-01
通讯作者: ^*cenying—pls@foxmail.com
基金资助:
四川省自然科学基金(2022NSFSC1395)

Progress on the role of exosomal miRNAs in organ fibrosis

FANG Lu¹, LIU Ruiqi², LIANG Peng¹, CEN Ying^2*

1. Department of Day Surgery Center, General Practice Medical Center; 2. Department of Burn and Plastic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China

Received:2022-09-05 Revised:2023-02-27 Online:2023-09-05 Published:2023-09-01
Contact: ^*cenying—pls@foxmail.com

摘要/Abstract

摘要： 外泌体是由多种细胞主动分泌产生的可携带蛋白质、脂质、miRNAs等生物分子的微小囊泡。外泌体微小RNAs(miRNAs)稳定的存在于体液循环中,参与器官多项病理过程。在器官纤维化疾病中,外泌体miRNAs的含量与正常组织相比呈现出明显的差异性表达,通过调控不同信号通路促进或抑制器官纤维化。外泌体miRNAs可作为临床诊断器官纤维化及判断其纤维化程度的最新生物指标和纤维化疾病新的治疗靶点。

关键词: 外泌体, 外泌体miRNAs, 纤维化疾病

Abstract: Exosomes are tiny vesicles that are actively secreted by a variety of cells, which regulate various physiological and pathological processes of the body by carrying proteins, lipids, miRNAs and other biological molecules. Exocrine microRNAs(miRNAs) stably exist in the body fluid circulation and participate in many pathological processes of organs. In organ fibrosis disease, the content of the exosomal miRNAs shows significant differential expression profile as compared with normal tissues, and promotes or inhibits organ fibrosis by regulating different signal pathways. It is considered to be the latest biological indicator for diagnosing organ fibrosis and judging its degree of fibrosis, and a new therapeutic target for fibrosis disease.

Key words: exosome, exosomal miRNAs, fibrotic disease

中图分类号:

方路, 刘睿奇, 梁鹏, 岑瑛. 外泌体miRNAs在器官纤维化中作用的研究进展[J]. 基础医学与临床, 2023, 43(9): 1472-1476.

FANG Lu, LIU Ruiqi, LIANG Peng, CEN Ying. Progress on the role of exosomal miRNAs in organ fibrosis[J]. Basic & Clinical Medicine, 2023, 43(9): 1472-1476.

参考文献 25

[1]	Kalluri R, Lebleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367.doi: 10.1126/science.aau6977.
[2]	Chen L, Chen R, Kemper S, et al. Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309: G491-499.
[3]	Chen J, Yu Y, Li S, et al. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy[J]. J Cell Mol Med, 2017, 21: 3679-3692.
[4]	Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J]. J Cell Mol Med, 2017, 21: 2491-2502.
[5]	Sun C, Shi C, Duan X, et al. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4[J]. Bioengineered, 2022, 13: 5915-5927.
[6]	Chen L, Huang Y, Duan Z, et al. Exosomal miR-500 derived from lipopolysaccharide-treated macrophage accele-rates liver fibrosis by suppressing MFN2[J]. Front Cell Dev Biol, 2021, 9. doi: 10.3389/fcell.2021.716209.eCollection2021.
[7]	Zhao S, Li W, Yu W, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys[J]. Theranostics, 2021, 11: 8660-8673.
[8]	Jin J, Qian F, Zheng D, et al. Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir[J]. Int J Nanomedicine, 2021, 16:3565-3578.
[9]	Li D, Qu J, Yuan X, et al. Mesenchymal stem cells alleviate renal fibrosis and inhibit autophagy via exosome transfer of miRNA-122a[J]. Stem Cells Int, 2022, 2022(1981798). doi: 10.1155/2022/1981798.eCollection2022.
[10]	Liang M, Zhang D, Zheng D, et al. Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis[J]. Bioengineered, 2022, 13: 4517-4527.
[11]	Pan J, Alimujiang M, Chen Q, et al. Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1[J]. J Cell Biochem, 2019, 120: 4433-4443.
[12]	Ke X, Yang R, Wu F, et al. Exosomal miR-218-5p/miR-363-3p from endothelial progenitor cells ameliorate myocardial infarction by targeting the p53/JMY signaling pathway[J]. Oxid Med Cell Longev, 2021, 2021(5529430). doi: 10.1155/2021/5529430.eCollection2021.
[13]	Wang L, Liu J, Xu B, et al. Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure[J]. The Kaohsiung Journal of Medical Sciences, 2018, 34: 626-633.
[14]	Xu H, Ling M, Xue J, et al. Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking[J]. Theranostics, 2018, 8: 5419-5433.
[15]	Wang YC, Xie H, Zhang YC, et al. Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1alpha/Notch1/PDGFRbeta/YAP1/Twist1 axis in vitro[J]. Am J Physiol Heart Circ Physiol, 2021, 320: H520-H534.
[16]	Guiot J, Cambier M, Boeckx A, et al. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p[J]. Thorax, 2020, 75: 870-881.
[17]	Yao MY, Zhang WH, Ma WT, et al. MicroRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model[J]. Exp Mol Med, 2019, 51: 63.doi: 10.1038/s12276-019-0255-x.
[18]	Kadota T, Yoshioka Y, Fujita Y, et al. Extracellular vesicles from fibroblasts induce epithelial-cell senescence in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2020, 63: 623-636.
[19]	Li Y, Zhang J, Shi J, et al. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis[J]. Stem Cell Res Ther, 2021, 12: 221. doi: 10.1186/s13287-021-02290-0.
[20]	Li Q, Fang L, Chen J, et al. Exosomal microRNA-21 promotes keloid fibroblast proliferation and collagen production by inhibiting smad7[J]. J Burn Care Res, 2021, 42: 1266-1274.
[21]	Wang Q, Wang H, Jing Q, et al. Regulation of pancreatic fibrosis by acinar cell-derived exosomal miR-130a-3p via targeting of stellate cell PPAR-gamma[J]. J Inflamm Res, 2021, 14:461-477.
[22]	Zhang Y, Chang X, Wu D, et al. Down-regulation of exosomal miR-214-3p targeting CCN2 contributes to endometriosis fibrosis and the role of exosomes in the horizontal transfer of miR-214-3p[J]. Reprod Sci, 2021, 28: 715-727.
[23]	Xiao B, Zhu Y, Huang J, et al. Exosomal transfer of bone marrow mesenchymal stem cell-derived miR-340 attenuates endometrial fibrosis[J]. Biol Open, 2019, 8. doi: 10.1242/bio.039958.
[24]	Li D, Zhang J, Liu Z, et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6[J]. Stem Cell Res Ther, 2021, 12: 24. doi: 10.1186/s13287-020-02064-0.
[25]	Shen T, Zheng Q, Luo H, et al. Exosomal miR-19a from adipose-derived stem cells suppresses differentiation of corneal keratocytes into myofibroblasts[J]. Aging (Albany NY), 2020, 12: 4093-4110.

外泌体miRNAs在器官纤维化中作用的研究进展

Progress on the role of exosomal miRNAs in organ fibrosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	于曼殊, 赵晓敏, 邱明月, 刘春冉, 那日苏. 牙源性干细胞治疗帕金森病的研究进展[J]. 基础医学与临床, 2024, 44(9): 1298-1302.
[2]	赵俊丽, 朱君君, 詹秋楠, 刘苗. 骨髓间充质干细胞来源外泌体抑制高糖诱导的腹膜间皮细胞EMT[J]. 基础医学与临床, 2024, 44(8): 1149-1156.
[3]	高璐, 蔡孟华, 许依, 何维, 陈慧, 张建民. 过表达膜定位IL-3的293T细胞外泌体的纯化及体外功能验证[J]. 基础医学与临床, 2024, 44(7): 947-953.
[4]	颜晨红, 金儿. 外泌体PD-L1在非小细胞肺癌诊断和治疗上的研究进展[J]. 基础医学与临床, 2023, 43(9): 1457-1461.
[5]	杨雅倩, 潘艳芳, 屈梦扬, 方艳, 应小平, 张玫倩, 魏静. 外泌体在肝癌前病变发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(9): 1453-1456.
[6]	陈星星, 赛依帕, 胡筱霞, 王三萍, 罗璇, 刘璟. 人脐带间充质干细胞来源外泌体对脑瘫小鼠神经功能损伤的保护作用[J]. 基础医学与临床, 2023, 43(8): 1201-1207.
[7]	闫霖, 陆珏秀, 罗颖, 刘先霞. BM-MSCs来源外泌体介导铁死亡减轻大鼠心肌细胞系H9c2缺氧/复氧损伤[J]. 基础医学与临床, 2023, 43(5): 771-776.
[8]	崔诗雨, 张海峰. 外泌体在新型冠状病毒感染和传播中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 680-684.
[9]	徐倩, 段华, 甘露, 刘麒薇. RhoGTP酶活化蛋白在上皮细胞间质转化中作用的研究进展[J]. 基础医学与临床, 2023, 43(2): 301-305.
[10]	姚刘旭, 李玉红, 蒋宗明. 外泌体lncRNA在结直肠癌液体活检中的研究进展[J]. 基础医学与临床, 2023, 43(2): 317-321.
[11]	姜俣, 钱海燕. 间充质干细胞治疗心肌梗死的研究进展[J]. 基础医学与临床, 2023, 43(1): 21-29.
[12]	商利鹏, 刘国祥, 丁晓燕, 李冰, 赵春华, 李霄霞. 间充质干细胞在衰老相关疾病应用中的研究进展[J]. 基础医学与临床, 2023, 43(1): 38-45.
[13]	陈莉莉, 孙永红, 雷晓燕, 王建军, 陈星星, 鲍柏辛. 间充质干细胞外泌体治疗肺部疾病的研究进展[J]. 基础医学与临床, 2023, 43(1): 192-195.
[14]	李英杰, 杨庭楷, 纪志刚, 文进. 外泌体在前列腺癌诊疗中的研究进展[J]. 基础医学与临床, 2022, 42(1): 163-167.
[15]	杨旭东, 于红亮, 李静, 赵春华. 巨噬细胞J774A.1外泌体促进结直肠癌细胞系MC38和CT26的增殖和迁移[J]. 基础医学与临床, 2021, 41(6): 799-804.